Literature DB >> 18937081

Spinal drop metastases from a papillary meningioma: a case report and review of the literature: utility of CSF sampling.

Ibrahim Erkutlu1, Hakan Buyukhatipoglu, Mehmet Alptekin, Eser Berkyurek, Ediz Tutar, Abdulvahap Gok.   

Abstract

In this paper, we report a rare case of a 29-year-old boy who presented with papillary meningioma originating from the posterior fossa meninges. After a long, disease-free period, however, spinal drop metastases occurred 32 months after resection of the primary tumor. The primary and metastatic lesions had a similar histological appearance, meaning that multiple spinal metastatic lesions occurred through CSF route even after a gross total resection of the tumor. Tumor seeding during surgery is the evident reason for spinal metastasis, although we strictly adhered to the standard precautions for operations for malignant tumors such as obstruction of the cisterna magna with cotton paddies, and changing surgical gloves and instruments during the operation. In this report, we briefly discuss an exceedingly rare variant of meningioma, the papillary variant, and suggest a new approach, a CSF sampling, in the management of both malignant and benign meningiomas. CSF sampling allows for the early detection of metastasis and of tumor cells before metastasis has occurred, thus allowing treatment to begin as soon as possible. This early detection and management is possibly associated with longer survival. Furthermore, we discussed that meningiomas are tumors that are not as benign as initially thought.

Entities:  

Mesh:

Year:  2008        PMID: 18937081     DOI: 10.1007/s12032-008-9101-z

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  13 in total

1.  "Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.

Authors:  A Perry; B W Scheithauer; S L Stafford; C M Lohse; P C Wollan
Journal:  Cancer       Date:  1999-05-01       Impact factor: 6.860

Review 2.  Seeding of malignant meningioma along a surgical trajectory on the scalp. Case report and review of the literature.

Authors:  Wolf O Lüdemann; Richard Obler; Marcos Tatagiba; Madjid Samii
Journal:  J Neurosurg       Date:  2002-09       Impact factor: 5.115

Review 3.  Papillary meningioma with pleural metastasis: case report and literature review.

Authors:  J M Kros; F Cella; S L Bakker; D Paz Y Geuze; R M Egeler
Journal:  Acta Neurol Scand       Date:  2000-09       Impact factor: 3.209

4.  Malignant meningioma metastasizing through the cerebrospinal pathways.

Authors:  S K Ludwin; F K Conley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-02       Impact factor: 10.154

5.  Cerebrospinal fluid-disseminated meningioma.

Authors:  Marc C Chamberlain; Michael J Glantz
Journal:  Cancer       Date:  2005-04-01       Impact factor: 6.860

6.  Papillary meningioma: a malignant variant of meningioma.

Authors:  S K Ludwin; L J Rubinstein; D S Russell
Journal:  Cancer       Date:  1975-10       Impact factor: 6.860

7.  Repeated multifocal recurrence of grade I, grade II, and grade III meningiomas: regional multicentricity (primary new growth) or metastases?

Authors:  J de Vries; A K Wakhloo
Journal:  Surg Neurol       Date:  1994-04

Review 8.  Epidemiology of intracranial meningioma.

Authors:  W T Longstreth; L K Dennis; V M McGuire; M T Drangsholt; T D Koepsell
Journal:  Cancer       Date:  1993-08-01       Impact factor: 6.860

9.  Benign metastasizing meningioma. Case report.

Authors:  D C Miller; R G Ojemann; K H Proppe; B D McGinnis; H C Grillo
Journal:  J Neurosurg       Date:  1985-05       Impact factor: 5.115

10.  Papillary meningioma. Clinicopathologic study of seven cases and review of the literature.

Authors:  B Pasquier; F Gasnier; D Pasquier; E Keddari; A Morens; P Couderc
Journal:  Cancer       Date:  1986-07-15       Impact factor: 6.860

View more
  7 in total

1.  Methylation of Werner syndrome protein is associated with the occurrence and development of invasive meningioma via the regulation of Myc and p53 expression.

Authors:  Puxian Li; Shuyu Hao; Zhiyong Bi; Junting Zhang; Zhen Wu; Xiaohui Ren
Journal:  Exp Ther Med       Date:  2015-05-26       Impact factor: 2.447

2.  Systematic Analysis of Outcomes for Surgical Resection and Radiotherapy in Patients with Papillary Meningioma.

Authors:  Christina Fong; Daniel T Nagasawa; Lawrance K Chung; Brittany Voth; Nicole Cremer; Kimberly Thill; Nolan Ung; Quinton Gopen; Isaac Yang
Journal:  J Neurol Surg B Skull Base       Date:  2015-03-12

Review 3.  Current management of choroid plexus carcinomas.

Authors:  Matthew Z Sun; Michael C Oh; Michael E Ivan; Gurvinder Kaur; Michael Safaee; Joseph M Kim; Joanna J Phillips; Kurtis I Auguste; Andrew T Parsa
Journal:  Neurosurg Rev       Date:  2013-09-26       Impact factor: 3.042

4.  Papillary meningioma: clinical and histopathological observations.

Authors:  Dai-Jun Wang; Ming-Zhe Zheng; Ye Gong; Qing Xie; Yin Wang; Hai-Xia Cheng; Ying Mao; Ping Zhong; Xiao-Ming Che; Cheng-Chuan Jiang; Feng-Ping Huang; Kang Zheng; Shi-Qi Li; Yu-Xiang Gu; Wei-Min Bao; Bo-Jie Yang; Jing-Song Wu; Li-Qian Xie; Hai-Liang Tang; Hong-Da Zhu; Xian-Cheng Chen; Liang-Fu Zhou
Journal:  Int J Clin Exp Pathol       Date:  2013-04-15

5.  Intracranial meningioma with leptomeningeal dissemination : retrospective study with review of the literature.

Authors:  Ki-Su Park; Ki-Hong Kim; Seong-Hyun Park; Jeong-Hyun Hwang; Dong-Hyun Lee
Journal:  J Korean Neurosurg Soc       Date:  2015-04-24

6.  Iatrogenic Seeding of Tumor Cells in Thigh Soft Tissue Upon Surgical Removal of Intracranial Meningioma.

Authors:  Ghodratollah Maddah; Hossein Shabahang; Vahid Zehi; Nouriyeh Sharifi Sistani; Hossein Mashhadi Nejad
Journal:  Basic Clin Neurosci       Date:  2016-04

7.  Isolated Extracranial Intraosseous Metastasis of an Intracranial Meningioma following Bevacizumab Therapy: Case Report and Review of the Literature.

Authors:  Debraj Mukherjee; Jethro L Hu; Ray M Chu
Journal:  Asian J Neurosurg       Date:  2018 Jan-Mar
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.